Clinical Medical practitioners are accredited to administer Schedule II, III, IV, and V prescription drugs, although not Program I, so they may have to use for the DEA for Exclusive authorization to administer a Program I drug specifically while in the context with the review, Halpern stated.In MAPS’s case, the health practitioner involved is Dr.